Status:
COMPLETED
Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Locally Advanced Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial examines a group-mediated cognitive behavioral resistance exercise intervention in head and neck cancer patients who are undergoing chemoradiation treatment. Chemoradiation is the ...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the feasibility of implementing a group-mediated cognitive behavioral (GMCB) personalized resistance exercise (RE) intervention in head and neck cancer (HNCa) pati...
Eligibility Criteria
Inclusion
- Patients with locally advanced human papillomavirus (HPV)+ stage III-IV head and neck (HN) squamous cell carcinomas undergoing concurrent chemotherapy and radiation therapy. Patients with prior cancers or post-surgical patients needing adjuvant therapy will not be allowed to participate in this study
- Undergoing planned course of standard of care CRT for a total of 33 to 35 RT fractions (six and a half or seven weeks of treatment)
- Adults 18 years old (yo) or older who have clearance from their primary care provider (PCP) or medical oncologist to participate in resistance exercises during treatment. These patients will be monitored very closely on a weekly basis during the trial
- All participants must be free of severe heart or systemic disease or medical contraindications that would make supervised RE participation unsafe
- Receive medical clearance to participate from treating primary care physician or Medical Oncologists
- Ability to understand and the willingness to sign a written informed consent
- Willing and physically able to participate in RE
Exclusion
- Severe heart or systemic disease or medical contraindications to exercise
- Diagnosis of cancer other than HNCa
- Musculoskeletal/Neurological disorder inhibiting them from safe exercise
- Pregnant or nursing women
- Unable to give informed consent
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04733495
Start Date
April 19 2021
End Date
February 20 2023
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210